Shuttle Pharmaceuticals Files Definitive Proxy Statement
Ticker: SHPH · Form: DEF 14A · Filed: May 6, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | DEF 14A |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: SHPH
TL;DR
Shuttle Pharma (SHPH) dropped its proxy statement - shareholders vote soon on board, pay, etc.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed its definitive proxy statement on May 7, 2025, for its annual meeting. The filing, designated as DEF 14A, outlines the company's governance and proposals for shareholder vote. Key details regarding executive compensation, director elections, and other corporate matters are expected to be detailed within the full proxy statement.
Why It Matters
This filing is crucial for shareholders as it details how the company is run, who is on the board, and how executives are compensated, allowing shareholders to make informed voting decisions.
Risk Assessment
Risk Level: medium — Proxy statements are routine filings, but the specific proposals and company performance discussed within can carry significant implications for investors.
Key Numbers
- 20250507 — Filing Date (This is the date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- 0001757499 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-41488 (company) — SEC File Number
- 25919527 (company) — Film Number
- 20250507 (date) — Filing Date
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, detailing important information such as director nominations, executive compensation, and other corporate actions.
When was this specific proxy statement filed?
This definitive proxy statement was filed on May 7, 2025.
What is the company's Central Index Key (CIK)?
The Central Index Key for Shuttle Pharmaceuticals Holdings, Inc. is 0001757499.
What is the Standard Industrial Classification code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's business address?
The business address for Shuttle Pharmaceuticals Holdings, Inc. is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 6, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).